ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

OPTION AGREEMENT - CERTIFICATE

The following (this “Award Agreement”) evidences the grant of an option (the “Option”) to purchase Shares of Ulta Beauty, Inc. (the “Company”) pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”) to the following individual (the “Optionee”) and upon the following terms:  

Optionee:	Name**: Address: **​Location-
Grant Date:	​
Exercise Price Per Share:	​
Total Number of Options Granted:	​
Type of Option:	​

If designated as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option as defined in Section 422 of the Code; provided, however, that to the extent that it does not so qualify that portion which does not so qualify shall be treated as a Non-Qualified Stock Option.

Unless otherwise defined herein, capitalized terms used in this Award Agreement shall have the same meanings as set forth in the Plan.

…

ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

Ulta Beauty, Inc. (the “Company”), pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”), hereby grants the number of Restricted Stock Units (each, an “RSU”) set forth below to the following individual (the “Holder”), subject to the restrictions on transfer and forfeiture and such other limitations set forth herein and in the Plan. Each RSU entitles the Holder to receive an equal number of Shares at settlement, as described herein.

**Name:**​	**Address:**​
Grant Date	​
Total Number of RSUs Granted	​

Unless otherwise defined herein, capitalized terms used in this agreement (this “Award Agreement”) shall have the same meanings set forth in the Plan.

1.Vesting Schedule.  The RSUs are subject to the restrictions on transfer set forth in Section 2 and may be forfeited as provided in Section 4 until vested. Once vested, the RSUs shall be settled and paid on the dates and as provided in Section 5. Holder shall vest in full in the RSUs on the earliest of:

(a)[______________];

…

CHANGE IN CONTROL SEVERANCE AGREEMENT

THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of August 27, 2026 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”) and Christian Maingot (the “Executive”).

W I T N E S S E T H

WHEREAS, the Committee (as defined in Section 1) has determined that it is in the best interests of the Company and its stockholders to secure the Executive’s continued services and objectivity in the event of any threat or occurrence of, or negotiation or other action that could lead to, or create the possibility of, a Change in Control (as defined in Section 1) of the Company, without concern as to whether the Executive might be hindered or distracted by personal uncertainties and risks created by any such possible Change in Control, and to encourage the Executive’s full attention and dedication to the Company, and in order to further such interests, the Committee has authorized the Company to enter into this Agreement.

NOW, THEREFORE, in consideration of the mutual promises, covenants, representations and warranties contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1.Definitions. As used in this Agreement, the following terms shall have the respective meanings set forth below:

a.“Board” means the Board of Directors of the Company.

…

PagerDuty, Inc.

600 Townsend Street, Suite 200

San Francisco, CA 94103

June 4, 2026

Dear Eric Prengel,

On behalf of PagerDuty, Inc., a Delaware corporation (the “Company”), I am pleased to offer you the position of Chief Financial Officer of the Company, subject to your formal appointment by the Board of Directors. We believe that you will add substantially to the team and contribute greatly to the ultimate success of the Company by providing the Company with the same extraordinary leadership and vision that you have demonstrated throughout your career. The existing PagerDuty team and I look forward to your help in building PagerDuty into a great company.

We understand and appreciate the nature of the commitment you are making to join the Company, and we want you to do so with great confidence. You have the qualities that distinguish successful executives: leadership, vision, high integrity, intelligence, a bias to action, and a desire to make a difference. We are extremely enthusiastic about your accepting this offer.

The terms of your employment with the Company are as set forth in the agreement (“Agreement”) below:

1.Position.

(a)You will become Chief Financial Officer, reporting directly to the Company’s Chief Executive Officer, subject to formal appointment by the Board of Directors.

…

THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

CONVERTIBLE PROMISSORY NOTE

Date of Note: August 25, 2026

Initial Principal Amount: $162,500.00

For value received Bion Environmental Technologies, Inc., a Colorado corporation, BION TECHNOLOGIES, INC., and BION 3G-1 LLC (each individually and, collectively, from time to time, the “Company” or “Bion Group”), jointly and severally promise to pay to North Prairie Holdings, LLC, a Michigan limited liability company, or such party’s assigns (the “Holder”) the principal amount of One Hundred Sixty-Two Thousand Five Hundred and 00/100 Dollars ($162,500.00), representing Company’s delinquent rent obligations to Holder under the Lease (as defined below) as of the date of this Note, as such amount may be increased from time to time by the accrual of Lease Payments pursuant to Section 2 below (as so increased from time to time, the outstanding principal amount is referred to herein as the “Principal Amount”), together with interest on the outstanding Principal Amount at the rate of 10% per annum, compounded monthly. Interest shall commence with the date of this Note and shall continue on the

…

SETTLEMENT AND MUTUAL RELEASE AGREEMENT

This Settlement and Mutual Release Agreement ("Settlement Agreement") is entered into by and between BION ENVIRONMENTAL TECHNOLOGIES, INC. ("BION"), BION TECHNOLOGIES, INC. ("BION TECH"), BION 3G-1 LLC ("3G-1"), (from time to time collectively referred to as “Bion” or "Bion Group"), and NORTH PRAIRIE HOLDINGS, LLC ("NPH"). The parties to this Settlement Agreement are referred to herein from time to time as the "Parties," or each singularly, as a "Party." The "Effective Date" is August 25, 2026.

Recitals

WHEREAS, BION TECH and 3G-1 are subsidiaries and/or affiliates of BION.

WHEREAS, NPH is owner of approximately 20 acres of real property located at 5093 East 700 North, Fair Oaks, Newton County, Indiana (the "Property").

WHEREAS, 3G-1 entered into a lease agreement with NPH on September 23, 2021 (the "Lease") for a portion of the Property, consisting of approximately four (4) acres, originally for the purpose of constructing and operating a small beef cattle finishing facility, including a Bion 3G Tech livestock waste treatment system at the location. The Lease is attached to this Agreement as Exhibit A.

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL, AND HAS BEEN MARKED WITH

“[***]” TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.

KEYEXECUTIVEBENEFITSAGREEMENT

LifeVantage Corporation (the "Company") has established this Key Executive Benefits Agreement (the "Agreement") to attract, motivate and retain certain key executives of the Company. An employee is considered a Key Executive upon approval by the Company's Compensation Committee. You shall be considered a Key Executive of the Company. This Agreement is entered into between the Company and Terrence Moorehead (“Key Executive” or “you”) effective as ofAugust 5, 2026.

ThetermsandconditionsofthisAgreementareasfollows:

1.

PositionandResponsibilities.

a.

No later thanAugust 5, 2026, you will commence serving as a key management executive of the Company as its President and Chief Executive Officer.You shall be a member of the Company’s Board of Directors. You shall have the duties, responsibilities, and authority that are customarily associated with such position and such other senior management duties as may reasonably be assigned consistent with your position. You will devote your full time, efforts, abilities, and energies to promote the general welfare and interests of the Company and any related enterprises of the Company. Unless otherwise approved in writing by the Chairman of the Company's Board of Directors, your primary workplace will be located at the Company's headquarters located in

…

--

714508044v4

Exhibit 10.11

AMENDMENTNO.1TOLOANAGREEMENTANDCONSENT

This Amendment No. 1 to Loan Agreement and Consent (the “Amendment”), dated as of September22, 2025, is between Bank of America, N.A. (the “Bank”) and LifeVantage Corporation, a Delaware corporation (the “Borrower”).

RECITALS

A.

The Bank and the Borrower entered into a certain Loan Agreement dated as of April12, 2024 (together with any previous amendments or supplements thereto, the “Loan Agreement”).

B.

The Borrower has informed the Bank that, pursuant to that certain Asset Purchase Agreement, dated as of September3, 2025, by and among Global Organics Merchants, LLC, a Delaware limited liability company (“Seller”), the Borrower, as the buyer thereunder, and the other parties thereto (the “Asset Purchase Agreement”), the Borrower intends to purchase or otherwise acquire the Acquired Assets and the Assumed Liabilities (as such terms are defined in the Asset Purchase Agreement), but excluding in all events the Excluded Assets and the Excluded Liabilities (as such terms are defined in the Asset Purchase Agreement) (collectively, the “Asset Acquisition”).

C.

…

DIRECTORSHIP AGREEMENT

This directorship agreement (the ‘Agreement’) is entered into on March 28th 2026

between

** **

Terra Innovatum Global N.V., a Dutch public limited liability company, with legal seat in Amsterdam, the Netherlands, registered with the Dutch trade register under number 98523554 (hereinafter, the Company”)

and

** **

Ms. Katherine Williams, born on 15th August, in 1957 (the “Manager”)

(the Company, on the one hand, and the Manager, on the other hand, are collectively referred to as the Parties’ and individually as a Party’)

WHEREAS

** **

**(A) **the Manager has been appointed on 28th March as an executive director of the Company to cover the role of Chief Financial Officer (the “Office”) until after the close of the annual general meeting of the Company to be held in 2027, relevant for the approval of the financial statements referrable to fiscal year 2026;

**(B) **the Manager is also employed by Terra Innovatum Corp. a U.S. based subsidiary of the Company within the Group (the “US Subsidiary”) under an employment agreement granting an overall compensation covering any assignment or position held by the Manager within the Group, including the Office, separately governed by a specific employment agreement (the “US Employment Relationship”);

(C) the Parties intend to determine with this agreement (the Agreement”) terms and conditions of the Office.

** **

WHEREAS, the Parties agree as follows:

	1.	BACKGROUND

** **

…

EMPLOYMENT AGREEMENT

EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 28, 2026, between Terra Innovatum Corp. (the “Company”) and Katherine Williams (“Executive,” together with the Company, the “Parties” and, each, a “Party”).

WHEREAS, the Company desires to employ Executive, and Executive desires to accept such employment, on the terms and conditions set forth in this Agreement;

NOW, THEREFORE, on the basis of the foregoing premises and in consideration of the mutual covenants and agreements contained herein, the Parties agree as follows:

1. Employment; Title; Duties and Location. The Company hereby agrees to employ Executive, and Executive hereby accepts employment with the Company, on the terms and subject to the conditions set forth herein. During the Employment Period (as defined in Section 2 below), Executive shall serve the Company as Chief Financial Officer. Executive shall perform the duties consistent with Executive’s title and position and such other duties commensurate with such position and title as shall be specified or designated by the Company from time to time. Subject to Executive’s appointment thereto, Executive shall hold such other or additional titles and serve, during the Employment Period, in such other or additional capacities to which Executive may be appointed from time to time in the Company and any Company Affiliates (defined below) (the “Additional Assignments”), provided such Additional Assignments are consistent with Executive’s above-stated position and duties and any additional compensation with respect to

…

AMENDEDANDRESTATEDEMPLOYMENTAGREEMENT

THIS    AMENDED    AND    RESTATED    EMPLOYMENT    AGREEMENT    (this

“Agreement”), is entered into on October 19, 2026 (the “Effective Date”), by and among SUN COMMUNITIES, INC., a Maryland corporation (the “REIT”), SUN COMMUNITIES OPERATING LIMITED PARTNERSHIP, a Michigan limited partnership (“SCOLP”), and AARON WEISS (the “Executive”).As used herein, “Company” shall refer to the REIT and SCOLP together.

W IT NE S S ET H:

WHEREAS, SCOLP operates the business of the REIT; WHEREAS,theREITisthesolegeneralpartnerofSCOLP;

WHEREAS, the Executive is currently an employee of the Company, providing services to the Company pursuant to the Employment Agreement dated October 18, 2021, as amended (the “Prior Employment Agreement”) among the Executive, the REIT and SCOLP;

WHEREAS, the Company desires to continue the employment of the Executive, under which he will provide services to the Company, and the Executive desires to be employed by the Company; and

WHEREAS, the Company and the Executive desire to amend and restate the Prior EmploymentAgreementinitsentirety,onthetermsandsubjecttotheconditionssetforthbelow.

NOW,THEREFORE,inconsiderationofthemutualpromisescontainedinthisAgreement and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties agree as follows:

1.Employment.

…

Exhibit 10.21

Page 1 of 21

EXECUTIVE EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is entered into and effective as of April 6, 2026 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and * *Paul Miele (“Executive”).

RECITALS

A.**    **The Company is in the business of developing, manufacturing and selling radiation oncology, including radio surgery and radiation therapy, technologies and devices (the “Business”).

B.**    **The Company wishes to employ Executive to serve as Senior Vice President, Chief Commercial Officer and Executive desires to serve the Company in such capacity pursuant to the terms and conditions in this Agreement.

C.**    **As of the Effective Date, Executive has commenced full-time employment with the Company.

NOW, THEREFORE, the parties agree as follows:

1.**    Position and Duties.**

(a)    During the term of this Agreement, Executive will be employed by the Company to serve as Senior Vice President, Chief Commercial Officer of the Company, reporting to the President and Chief Executive Officer of the Company. Executive will be responsible for: (i) performing the duties and responsibilities customarily expected to be performed by such position and (ii) performing such other duties and functions as are reasonably required and/or as may be reasonably prescribed by the Company from time to time.

…